<DOC>
	<DOCNO>NCT02395263</DOCNO>
	<brief_summary>The purpose study determine whether Yuxintine Capsule different dos effective treatment Depression . And explore preliminary information safety efficacy Yuxintine Capsule Chinese Patients Depression .</brief_summary>
	<brief_title>Comparison Yuxintine With Placebo Treatment MDD</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Adult primary diagnosis major depressive disorder ( MDD ) base criterion DSMIVTR , single episode recurrent episode , accompany psychotic symptom . Coding diagnosis include : 296.2 296.3 . The Subject HeartSpleen Deficiency base CTM . The total score MADRS ≥22 screen visit baseline visit . The total score HAMD17 ≥18 ≤30 , AND item 1 ≥2 screen visit baseline visit . The subject understands consent take part clinical trial . The subject sign inform consent . The subject make suicide attempt recent 6 month score ≥3 item 3 ( suicide assessment ) HAMD . The subject current DSMⅣTR axisⅠpsychiatric diagnosis depression . When MADRS score baseline visit compare screen visit , decrease rate ≥25 % . Any unstable cardiovascular , hepatic , renal , endocrine ( thyroid gland dysfunction ) , blood ( e.g . bleed tendency ) , medical disease . Had history seizure disorder , except infantile febrile convulsion . The subject accept psychosurgery electroconvulsive therapy within 3 month . With psychotic symptom . The subject history mania episode , include manic , mixed rapid cycle attack . The subject current diagnosis history depression due psychotic disorder general medical condition . The subject refractory depressive disorder , i.e.the patient use least two different mechanism antidepressant adequate dosage duration treatment still respond . Clinically significant electrocardiographic ( ECG ) abnormalities abnormal laboratory value ( eg . Hepatic function 1.5 time clinical toplimit , renal function index toplimit , abnormal coagulation function clinical significance abnormality , i.e . Prothrombin time shorten extend 3 second dynamic variation APTT prolong 10 second , AND fibrinogen L progressive decline , &gt; 4.0 g/L ) . The subject diagnosis alcohol substance abuse dependence least 1 year prior baseline visit . Known hypersensitivity Ginseng , least two kind drug , serious allergic physique . Women pregnant , breastfeeding , plan become pregnant study . Men request fertility study period . The subject could take safe effective birth control measure . The subject could take medication accord doctor 's advice . The subject use antidepressant drug normally 2 week screen , stop use psychotropic drug le 7 halflife period ( monoamine oxidase inhibitor 2 week ) . The subject participate drug clinical trial within 3 month screen . The investigator think subject unsuitable enrol clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>